Response to Comment on Curovic et al. Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial. Diabetes Care 2023;46:593-601

Diabetes Care. 2024 Feb 1;47(2):e21. doi: 10.2337/dci23-0046.

Authors

Viktor Rotbain Curovic¹, Frederik Persson¹, Niels Jongs², Hiddo J L Heerspink²

Affiliations

¹ Steno Diabetes Center Copenhagen, Herlev, Denmark.
² Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.

PMID: 38241497
DOI: 10.2337/dci23-0046

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Albuminuria* / drug therapy
Cross-Over Studies
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Humans
Insulin / therapeutic use
Rotation

Substances

Insulin